Personal Care Products

BRUUSH ORAL CARE INC

Bruush Oral Care to Reissue Financial Statements Due to Former Director's Misappropriation

OPTIMI HEALTH CORP

HCW Biologics

Silexion Therapeutics

Vida Global

GCL Global

BiomX

MetaVia

Micware

MicroAlgo

OLSI

BRSHF

LABD

On March 2, 2026, in Mississauga, Ontario, BioSyent Inc. completed the acquisition of Oral Science Inc., a private Canadian distributor from Brossard, Quebec. Oral Science specializes in healthcare products for dental hygiene and oral health. BioSyent, listed on TSX Venture as RX, successfully closed the acquisition deal, marking a significant milestone for the company. This acquisition allows BioSyent to expand its portfolio and reach in the healthcare sector, further solidifying its position in the market.

Unusual Whales

Origin Life Sciences

Direxion S&P Biotech Bear 3X

iShares Biotechnology ETF

SPDR S&P Health Equip

Minsheng Royal CSI Biotechnology Theme ETF

KETOP

ChinaAMC CSI All Share Health Care Devices ETF

VanEck Biotech ETF

ALPS Medical Breakthrough

E Fund CSI Biotechnology Theme ETF

Intelligent Bio Solutions

Bosera Hang Seng Health Care ETF(QDII)

Hwabao WP CSI Medical Service ETF

ChinaAMC CSI Biotechnology Theme ETF

Imagion Biosystems Ltd Warrant 2019-21.11.21 On Imagion Biosyst

China Merchants CSI Biotechnology Theme ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

SPDR S&P Biotech

BioSyent Inc. completes acquisition of Oral Science Inc., a dental hygiene product distributor based in Quebec.

UTRS

MMSI

SGRY

MAX Surgical Specialty Management has expanded its presence in New Jersey through a partnership with Dr. William G. Ranucci, adding Riverside Oral Surgery's location. Dr. Ranucci, a board-certified oral and maxillofacial surgeon, is recognized for his excellence and innovative techniques. The MAX network also welcomed Drs. Vincent Carrao and Kenneth Press, both esteemed leaders in the field. MAX, founded in 2022, aims to redefine oral and maxillofacial surgery by providing operational support while maintaining clinical autonomy for practices.

prnewswire

iShares US Medical Devices

Minerva Surgical

Merit Medical

Surgery Partners

Invesco Pharmaceuticals ETF

Health Care Select Sector SPDR

10:22 ETMAX Surgical Specialty Management Deepens New Jersey Presence Through New Partnership and Riverside Oral Surgery Expansion

Bruush Oral Care Inc. (BRSHF) announced on April 19, 2025, that its audited financial statements for the year ending October 31, 2022, are unreliable due to misappropriated funds by a former director. The company will restate these financials along with its 2023 statements, revealing a material weakness in internal controls. Remediation plans are being implemented, and the audit committee is working with independent auditors to resolve these issues. Bruush is based in Vancouver and focuses on oral hygiene products.

Tip Ranks

Bruush Oral Care Inc. to Restate 2022 Financial Statements Due to Misappropriation

BRUUSH ORAL CARE INC(BRSHF.US)

BioSyent Inc. completes acquisition of Oral Science Inc., a dental hygiene product distributor based in Quebec.

10:22 ETMAX Surgical Specialty Management Deepens New Jersey Presence Through New Partnership and Riverside Oral Surgery Expansion

Bruush Oral Care Inc. to Restate 2022 Financial Statements Due to Misappropriation